Bioventus
BVS
BVS
84 hedge funds and large institutions have $178M invested in Bioventus in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more capital invested
Capital invested by funds: $176M → $178M (+$1.5M)
0.83% more ownership
Funds ownership: 53.18% → 54% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
84
Holding in Top 10
3
Calls
$998K
Puts
$925K
Top Buyers
| 1 | +$1.63M | |
| 2 | +$1.19M | |
| 3 | +$1.17M | |
| 4 |
Goldman Sachs
New York
|
+$936K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$792K |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$892K | |
| 3 | -$330K | |
| 4 |
6CM
683 Capital Management
New York
|
-$297K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$291K |